Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 319

1.

Phase II Trial of Chemopreventive Effects of Levonorgestrel on Ovarian and Fallopian Tube Epithelium in Women at High Risk for Ovarian Cancer: An NRG Oncology Group/GOG Study.

Rodriguez GC, Kauderer J, Hunn J, Thaete LG, Watkin WG, Russell S, Yozwiak M, Basil J, Hurteau J, Lele S, Modesitt SC, Zivanovic O, Zhang HH, Bartels PH, Alberts DS.

Cancer Prev Res (Phila). 2019 Jun;12(6):401-412. doi: 10.1158/1940-6207.CAPR-18-0383. Epub 2019 Apr 23.

PMID:
31015198
2.

High Proportion of Nuclear Phenotype Identifies Aggressive Cutaneous Squamous Cell Carcinoma.

Glazer ES, Bartels PH, Liang J, Prasad AR, Yozwiak ML, Krutzsch M, Clark C, Kha S, Bartels HG, Einspahr JG, Alberts DS, Krouse RS.

Anal Quant Cytopathol Histpathol. 2015 Oct;37(5):302-9.

PMID:
26856115
3.

Quantitative histopathology identifies patients with thin melanomas who are at risk for metastases.

Glazer ES, Bartels PH, Lian F, Kha ST, Morgan SS, da Silva VD, Yozwiak ML, Bartels HG, Cranmer LD, de Oliveira JK, Alberts DS, Warneke JA, Krouse RS.

Melanoma Res. 2016 Jun;26(3):261-6. doi: 10.1097/CMR.0000000000000236.

PMID:
26795273
4.

Classification in karyometry: performance testing and prediction error.

Bartels PH, Bartels HG.

Anal Quant Cytopathol Histpathol. 2013 Aug;35(4):181-8.

5.

Karyometry of nuclear phenotypes in cutaneous squamous cell cancer.

Bartels PH, Bartels HG, Alberts DS, Yozwiak M, Prasad AR, Glazer ES, Krouse RS.

Anal Quant Cytol Histol. 2012 Feb;34(1):1-8.

6.

Karyometry in atypical endometrial hyperplasia: a Gynecologic Oncology Group study.

Bartels PH, Garcia FA, Trimble CL, Kauderer J, Curtin J, Lim PC, Hess LM, Silverberg S, Zaino RJ, Yozwiak M, Bartels HG, Alberts DS.

Gynecol Oncol. 2012 Apr;125(1):129-35. doi: 10.1016/j.ygyno.2011.12.422. Epub 2011 Dec 9.

7.

A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry.

Montironi R, Bartels PH, DeCensi A, Puntoni M, Hurle R, Decobelli O, Carmignani G, Mazzucchelli R, Bartels HG, Alberts DS, Maffezzini M.

Urol Oncol. 2013 Jul;31(5):557-65. doi: 10.1016/j.urolonc.2011.02.024. Epub 2011 Jul 23.

PMID:
21783387
8.

Global acetylation and methylation changes predict papillary urothelial neoplasia of low malignant potential recurrence: a quantitative analysis.

Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Cheng L, Bartels H, Bartels PH, Alberts DS, Montironi R.

Int J Immunopathol Pharmacol. 2011 Apr-Jun;24(2):489-97.

9.

Nuclear morphometry identifies a distinct aggressive cellular phenotype in cutaneous squamous cell carcinoma.

Glazer ES, Bartels PH, Prasad AR, Yozwiak ML, Bartels HG, Einspahr JG, Alberts DS, Krouse RS.

Cancer Prev Res (Phila). 2011 Nov;4(11):1770-7. doi: 10.1158/1940-6207.CAPR-10-0404. Epub 2011 Jun 2.

10.

Discriminant analysis.

Bartels PH, Bartels HG.

Anal Quant Cytol Histol. 2009 Oct;31(5):247-54.

PMID:
20701090
11.

A phase 2a study of topical perillyl alcohol cream for chemoprevention of skin cancer.

Stratton SP, Alberts DS, Einspahr JG, Sagerman PM, Warneke JA, Curiel-Lewandrowski C, Myrdal PB, Karlage KL, Nickoloff BJ, Brooks C, Saboda K, Yozwiak ML, Krutzsch MF, Hu C, Lluria-Prevatt M, Dong Z, Bowden GT, Bartels PH.

Cancer Prev Res (Phila). 2010 Feb;3(2):160-9. doi: 10.1158/1940-6207.CAPR-09-0183. Epub 2010 Jan 26.

12.

Knowledge discovery processing and data mining in karyometry.

Bartels PH, Montironi R, Scarpelli M, Bartels HG, Alberts DS.

Anal Quant Cytol Histol. 2009 Jun;31(3):125-36.

13.

Decision support systems for morphology-based diagnosis and prognosis of prostate neoplasms: a methodological approach.

Montironi R, Cheng L, Lopez-Beltran A, Mazzucchelli R, Scarpelli M, Bartels PH.

Cancer. 2009 Jul 1;115(13 Suppl):3068-77. doi: 10.1002/cncr.24345. Review.

14.

Karyometry: correction algorithm for differences in staining.

Bartels PH, Bartels HG, Alberts DS.

Anal Quant Cytol Histol. 2009 Apr;31(2):63-73.

15.

Progression of skin lesions from normal skin to squamous cell carcinoma.

Krouse RS, Alberts DS, Prasad AR, Yozwiak M, Bartels HG, Liu Y, Bartels PH.

Anal Quant Cytol Histol. 2009 Feb;31(1):17-25.

16.

Quantitative histopathology: the evolution of a scientific field.

Bartels PH, Montironi R.

Anal Quant Cytol Histol. 2009 Feb;31(1):1-4. No abstract available.

PMID:
19320187
17.

Actinic damage in histopathologically normal skin.

Bartels PH, Krouse RS, Prasad AR, Yozwiak M, Liu Y, Bartels HG, Alberts DS.

Anal Quant Cytol Histol. 2008 Dec;30(6):316-22.

18.

Digital image analysis of breast epithelial cells collected by random periareolar fine-needle aspirates (RPFNA) from women at high risk for breast cancer taking hormone replacement and the aromatase inhibitor, letrozole, for six months.

Frank DH, Kimler BF, Fabian CJ, Ranger-Moore J, Yozwiak M, Bartels HG, Alberts DS, Bartels PH.

Breast Cancer Res Treat. 2009 Jun;115(3):661-8. doi: 10.1007/s10549-008-0274-0. Epub 2009 Jan 6.

PMID:
19125322
19.

Limits of detection of chemopreventive efficacy: karyometry of skin biopsies.

Bartels PH, Yozwiak ML, Bartels HG, Liu Y, Hess LM, Alberts DS.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1689-95. doi: 10.1158/1055-9965.EPI-08-0313. Epub 2008 Jun 26.

20.

Karyometry of the colonic mucosa.

Alberts DS, Einspahr JG, Krouse RS, Prasad A, Ranger-Moore J, Hamilton P, Ismail A, Lance P, Goldschmid S, Hess LM, Yozwiak M, Bartels HG, Bartels PH.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2704-16.

21.

Early stromal invasion in cervical cancer: immunocytochemical changes occurring in infiltrating neoplastic cells.

Tarocco E, Mariuzzi L, Bettini R, Bartels PH, Mariuzzi G.

Adv Clin Path. 2001 Oct;5(4):133-8.

PMID:
17582937
22.

Karyometry of breast epithelial cells acquired by random periareolar fine needle aspiration in women at high risk for breast cancer.

Bartels PH, Fabian CJ, Kimler BF, Ranger-Moore JR, Frank DH, Yozwiak ML, Alberts DS.

Anal Quant Cytol Histol. 2007 Apr;29(2):63-70.

PMID:
17484269
23.

Chromatin phenotype karyometry can predict recurrence in papillary urothelial neoplasms of low malignant potential.

Montironi R, Scarpelli M, Lopez-Beltran A, Mazzucchelli R, Alberts D, Ranger-Moore J, Bartels HG, Hamilton PW, Einspahr J, Bartels PH.

Cell Oncol. 2007;29(1):47-58.

24.

Carcinogenesis and the hypothesis of phylogenetic reversion.

Bartels PH, Ranger-Moore J, Alberts D, Hess L, Scarpelli M, Montironi R.

Anal Quant Cytol Histol. 2006 Oct;28(5):243-52.

PMID:
17067006
25.

The evolution of scanning microphotometry: a historical review.

Bartels PH, Descour M, Alberts DS, Ranger-Moore J.

Anal Quant Cytol Histol. 2005 Dec;27(6):323-36.

PMID:
16450789
26.

Karyometry of infiltrating breast lesions.

Frank DH, Davis JR, Ranger-Moore J, Liu Y, Bartels HG, Alberts DS, Bartels PH.

Anal Quant Cytol Histol. 2005 Aug;27(4):195-201.

PMID:
16220830
27.

Karyometry in rectal mucosa of patients with previous colorectal adenomas.

Ranger-Moore J, Frank D, Lance P, Alberts D, Yozwiak M, Bartels HG, Einspahr J, Bartels PH.

Anal Quant Cytol Histol. 2005 Jun;27(3):134-42.

PMID:
16121634
28.

Karyometry in the early detection and chemoprevention of intraepithelial lesions.

Ranger-Moore J, Alberts DS, Montironi R, Garcia F, Davis J, Frank D, Brewer M, Mariuzzi GM, Bartels HG, Bartels PH.

Eur J Cancer. 2005 Sep;41(13):1875-88.

PMID:
16087328
29.

In memoriam George L. Wied, M.D., D.Sc. (hon), F.I.A.C. February 7, 1921-July 25, 2004.

Bartels PH.

Anal Quant Cytol Histol. 2004 Dec;26(6):301-3. No abstract available.

PMID:
15852560
30.

Second order discriminant analysis in chemopreventive efficacy measurement.

Bartels PH, Ranger-Moore J, Bartels HG, Alberts DS.

Anal Quant Cytol Histol. 2005 Feb;27(1):15-26.

PMID:
15794448
31.

Exploratory study of ovarian intraepithelial neoplasia.

Brewer MA, Ranger-Moore J, Baruche A, Alberts DS, Greene M, Thompson D, Liu Y, Davis J, Bartels PH.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):299-305.

32.

An array microscope for ultrarapid virtual slide processing and telepathology. Design, fabrication, and validation study.

Weinstein RS, Descour MR, Liang C, Barker G, Scott KM, Richter L, Krupinski EA, Bhattacharyya AK, Davis JR, Graham AR, Rennels M, Russum WC, Goodall JF, Zhou P, Olszak AG, Williams BH, Wyant JC, Bartels PH.

Hum Pathol. 2004 Nov;35(11):1303-14.

PMID:
15668886
33.

Karyometry detects subvisual differences in chromatin organisation state between non-recurrent and recurrent papillary urothelial neoplasms of low malignant potential.

Scarpelli M, Montironi R, Tarquini LM, Hamilton PW, López Beltran A, Ranger-Moore J, Bartels PH.

J Clin Pathol. 2004 Nov;57(11):1201-7.

34.

Preneoplastic changes in ovarian tissues.

Brewer MA, Ranger-Moore J, Greene MH, Alberts DS, Liu Y, Bartels HG, Baruch AC, Bartels PH.

Anal Quant Cytol Histol. 2004 Aug;26(4):207-16.

PMID:
15457673
35.

The use of morphological characteristics and texture analysis in the identification of tissue composition in prostatic neoplasia.

Diamond J, Anderson NH, Bartels PH, Montironi R, Hamilton PW.

Hum Pathol. 2004 Sep;35(9):1121-31.

PMID:
15343515
36.

Karyometric analysis of actinic damage in unexposed and sun-exposed skin and in actinic keratoses in untreated individuals.

Ranger-Moore J, Bartels PH, Bozzo P, Einspahr J, Liu Y, Saboda K, Alberts DS.

Anal Quant Cytol Histol. 2004 Jun;26(3):155-65.

PMID:
15218692
37.

Karyometric image analysis for intraepithelial and invasive cervical lesions.

Garcia FA, Ranger-Moore J, Barker B, Davis J, Brewer M, Lozevski J, Vinyak S, Liu Y, Yemane J, Hatch KD, Alberts DS, Bartels HG, Bartels PH.

Anal Quant Cytol Histol. 2004 Jun;26(3):141-50.

PMID:
15218690
38.

Karyometric features of low and high grade glial tumors as compared with their MRI appearance.

Scarpelli M, Montironi R, Salvolini U, Messori A, Bartels PH.

Anal Quant Cytol Histol. 2004 Apr;26(2):87-96.

PMID:
15131896
39.

Karyometry detects subvisual differences in chromatin organization state between cribriform and flat high-grade prostatic intraepithelial neoplasia.

Montironi R, Thompson D, Scarpelli M, Mazzucchelli R, Peketi P, Hamilton PW, Bostwick DG, Bartels PH.

Mod Pathol. 2004 Aug;17(8):928-37.

40.

A karyometric approach to the characterization of atypical endometrial hyperplasia with and without co-occurring adenocarcinoma.

Garcia FA, Davis JR, Alberts DS, Liu Y, Thompson D, Bartels PH.

Anal Quant Cytol Histol. 2003 Dec;25(6):339-46.

PMID:
14714300
41.

Computerized diagnostic decision support system for the classification of preinvasive cervical squamous lesions.

Price GJ, McCluggage WG, Morrison M ML, McClean G, Venkatraman L, Diamond J, Bharucha H, Montironi R, Bartels PH, Thompson D, Hamilton PW.

Hum Pathol. 2003 Nov;34(11):1193-203.

PMID:
14652822
42.

Subvisual changes in chromatin organization state are detected by karyometry in the histologically normal urothelium in patients with synchronous papillary carcinoma.

Montironi R, Scarpelli M, Mazzucchelli R, Hamilton PW, Thompson D, Ranger-Moore J, Bostwick DG, Bartels PH.

Hum Pathol. 2003 Sep;34(9):893-901.

PMID:
14562285
43.

Malignancy-associated changes in lactiferous duct epithelium.

Anderson N, Houghton J, Kirk SJ, Frank D, Ranger-Moore J, Alberts DS, Thompson D, Bartels PH.

Anal Quant Cytol Histol. 2003 Apr;25(2):63-72.

PMID:
12746974
44.

Statistical analysis of chemopreventive efficacy of vitamin A in sun-exposed, normal skin.

Bartels PH, Ranger-Moore J, Stratton MS, Bozzo P, Einspahr J, Liu Y, Thompson D, Alberts DS.

Anal Quant Cytol Histol. 2002 Aug;24(4):185-97.

PMID:
12199319
45.

Expert system support using a Bayesian belief network for the classification of endometrial hyperplasia.

Morrison ML, McCluggage WG, Price GJ, Diamond J, Sheeran MR, Mulholland KM, Walsh MY, Montironi R, Bartels PH, Thompson D, Hamilton PW.

J Pathol. 2002 Jul;197(3):403-14.

PMID:
12115888
46.

Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network.

Montironi R, Mazzucchelli R, Colanzi P, Streccioni M, Scarpelli M, Thompson D, Bartels PH.

Eur Urol. 2002 Apr;41(4):449-57.

PMID:
12074818
47.

Transcontinental communication and quantitative digital histopathology via the Internet; with special reference to prostate neoplasia.

Montironi R, Thompson D, Scarpelli M, Bartels HG, Hamilton PW, da Silva VD, Sakr WA, Weyn B, van Daele A, Bartels PH.

J Clin Pathol. 2002 Jun;55(6):452-60.

48.

Karyometry in endometrial adenocarcinoma of different grades.

Garcia FA, Davis JR, Hatch K, Alberts DS, Thompson D, Bartels PH.

Anal Quant Cytol Histol. 2002 Apr;24(2):93-102.

PMID:
12026057
49.

Quantitative study of breast cancer progression: different pathways for various in situ cancers.

Mariuzzi L, Mombello A, Granchelli G, Rucco V, Tarocco E, Frank D, Davis J, Thompson D, Bartels H, Mariuzzi GM, Bartels PH.

Mod Pathol. 2002 Jan;15(1):18-25.

50.

Nuclear chromatin characteristics of breast solid pattern ductal carcinoma in situ.

Frank DH, Davis JR, Alberts DS, Thompson D, Liu Y, Bartels PH.

Anal Quant Cytol Histol. 2001 Dec;23(6):418-26.

PMID:
11777277

Supplemental Content

Loading ...
Support Center